Tevogen Competitors
| TVGN Stock | 0.28 0.02 7.69% |
Tevogen Bio vs Fluoropharma Medical Correlation
Excellent diversification
The correlation between Tevogen Bio Holdings and FPMI is -0.55 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tevogen Bio Holdings and FPMI in the same portfolio, assuming nothing else is changed.
Moving together with Tevogen Stock
Moving against Tevogen Stock
| 0.85 | DRTS | Alpha Tau Medical | PairCorr |
| 0.79 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.74 | EQ | Equillium | PairCorr |
| 0.67 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.65 | DSGN | Design Therapeutics | PairCorr |
Tevogen Bio Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Tevogen Bio and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Tevogen and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Tevogen Bio Holdings does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tevogen Stock performing well and Tevogen Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tevogen Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KLDO | 146.28 | 71.85 | 0.00 | 3.50 | 0.00 | 0.00 | 4,998 | |||
| IVBT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| XENO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CALA | 21.70 | 5.80 | 0.08 | (1.58) | 20.34 | 100.00 | 280.00 | |||
| NMRD | 1.49 | (0.72) | 0.00 | 0.63 | 0.00 | 0.00 | 50.00 | |||
| SYVC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SNNAQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FPMI | 2.98 | 1.45 | 0.00 | 1.11 | 0.00 | 0.00 | 100.00 |
Cross Equities Net Income Analysis
Compare Tevogen Bio Holdings and related stocks such as Kaleido Biosciences, Innovation1 Biotech, and Xeno Transplants Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XENO | (46.7 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (230.7 K) | (242.3 K) |
| SYVC | (2.9 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (3.6 M) | (3.8 M) |
Tevogen Bio Holdings and related stocks such as Kaleido Biosciences, Innovation1 Biotech, and Xeno Transplants Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Tevogen Bio Holdings financial statement analysis. It represents the amount of money remaining after all of Tevogen Bio Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Tevogen Bio Competitive Analysis
The better you understand Tevogen Bio competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Tevogen Bio's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Tevogen Bio's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Tevogen Bio Competition Performance Charts
Five steps to successful analysis of Tevogen Bio Competition
Tevogen Bio's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Tevogen Bio Holdings in relation to its competition. Tevogen Bio's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Tevogen Bio in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Tevogen Bio's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Tevogen Bio Holdings, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Tevogen Bio position
In addition to having Tevogen Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Market ETFs Thematic Idea Now
Broad Market ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Market ETFs theme has 106 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Market ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Tevogen Bio Correlation with its peers. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Will Biotechnology sector continue expanding? Could Tevogen diversify its offerings? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Tevogen Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Tevogen Bio Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Tevogen Bio's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Tevogen Bio's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Tevogen Bio's market price signifies the transaction level at which participants voluntarily complete trades.